Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 10/2010

01.10.2010 | Head and Neck

Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?

verfasst von: Stephan K. Haerle, G. F. Huber, T. F. Hany, N. Ahmad, D. T. Schmid

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET)/CT imaging of squamous cell carcinoma of the head and neck (HNSCC) renders the possibility to study metabolic tumor activity by measuring FDG-uptake expressed as maximum standardized uptake value (SUVmax). A correlation between SUVmax and several factors including T-classification, histological tumor differentiation or different anatomic subsites is of potential interest in HNSCC. The aim of this study was to evaluate how metabolic tumor activity derived from FDG-PET correlates with prognostic clinical and pathological parameters including these factors. 262 patients with HNSCC undergoing PET/CT for initial staging were assessed separately for a potential correlation between SUVmax and T-classification, histological grading, and anatomical subsites of the primary tumor. Nonparametric testing showed a significant correlation between SUVmax and T-classification (P < 0.001). On the contrary, no statistically significant correlation was found between SUVmax and histological tumor grading. Furthermore, no statistical significant correlation between the different anatomical subsites and SUVmax were found. There was no significant correlation of SUVmax and tumor grading after adjustment for T-stage and anatomical localization of the tumor, neither. Conclusion: Metabolic tumor activity correlates with T-stage of HNSCC. However, histological tumor grading does not correlate with SUVmax. The role of primary tumor SUVmax as a predictor of outcome or survival remains unclear. Clinicians should therefore exercise caution in attributing any clinical importance to SUVmax obtained from a single PET/CT exam.
Literatur
1.
Zurück zum Zitat Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF (2009) Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 36:919–927. doi:10.1007/s00259-009-1064-6 CrossRefPubMed Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF (2009) Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 36:919–927. doi:10.​1007/​s00259-009-1064-6 CrossRefPubMed
2.
Zurück zum Zitat Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (2010) (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 32:319–325. doi:10.1002/hed.21184 PubMed Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (2010) (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 32:319–325. doi:10.​1002/​hed.​21184 PubMed
3.
Zurück zum Zitat Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Gregoire V (2010) Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 28:1190–1195. doi:10.1200/JCO.2009.24.6298 CrossRefPubMed Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, Bridji B, Digue L, Toubeau M, Gregoire V (2010) Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 28:1190–1195. doi:10.​1200/​JCO.​2009.​24.​6298 CrossRefPubMed
4.
Zurück zum Zitat Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS (2010) Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med 51:176–182. doi:10.2967/jnumed.109.067371 CrossRefPubMed Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS (2010) Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med 51:176–182. doi:10.​2967/​jnumed.​109.​067371 CrossRefPubMed
6.
Zurück zum Zitat Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201. doi:10.1002/hed.20942 CrossRefPubMed Machtay M, Natwa M, Andrel J, Hyslop T, Anne PR, Lavarino J, Intenzo CM, Keane W (2009) Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 31:195–201. doi:10.​1002/​hed.​20942 CrossRefPubMed
7.
Zurück zum Zitat Maccomb W, Fletcher G (196) Cancer of the head and neck. Williams & Wilkins Company, Baltimore, pp 152–292 Maccomb W, Fletcher G (196) Cancer of the head and neck. Williams & Wilkins Company, Baltimore, pp 152–292
8.
Zurück zum Zitat Chen RB, Suzuki K, Nomura T, Nakajima T (1993) Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis. J Oral Maxillofac Surg 51:397–401CrossRefPubMed Chen RB, Suzuki K, Nomura T, Nakajima T (1993) Flow cytometric analysis of squamous cell carcinomas of the oral cavity in relation to lymph node metastasis. J Oral Maxillofac Surg 51:397–401CrossRefPubMed
9.
Zurück zum Zitat Goerkem M, Braun J, Stoeckli SJ (2010) Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 17:527–535. doi:10.1245/s10434-009-0755-3 CrossRefPubMed Goerkem M, Braun J, Stoeckli SJ (2010) Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 17:527–535. doi:10.​1245/​s10434-009-0755-3 CrossRefPubMed
10.
Zurück zum Zitat Suzuki K, Nishioka T, Homma A, Tsuchiya K, Yasuda M, Aoyama H, Onimaru R, Tamaki N, Shirato H (2009) Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol 27:237–242. doi:10.1007/s11604-009-0330-7 CrossRefPubMed Suzuki K, Nishioka T, Homma A, Tsuchiya K, Yasuda M, Aoyama H, Onimaru R, Tamaki N, Shirato H (2009) Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol 27:237–242. doi:10.​1007/​s11604-009-0330-7 CrossRefPubMed
11.
Zurück zum Zitat Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL (1999) Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 213:521–525PubMed Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL (1999) Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 213:521–525PubMed
12.
Zurück zum Zitat Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW (2003) Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 113:888–891. doi:10.1097/00005537-200305000-00021 CrossRefPubMed Schmid DT, Stoeckli SJ, Bandhauer F, Huguenin P, Schmid S, von Schulthess GK, Goerres GW (2003) Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 113:888–891. doi:10.​1097/​00005537-200305000-00021 CrossRefPubMed
13.
Zurück zum Zitat Hustinx R, Lucignani G (2010) PET/CT in head and neck cancer: an update. Eur J Nucl Med Mol Imaging 37:645–651CrossRefPubMed Hustinx R, Lucignani G (2010) PET/CT in head and neck cancer: an update. Eur J Nucl Med Mol Imaging 37:645–651CrossRefPubMed
14.
Zurück zum Zitat Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71. doi:10.1007/s00259-002-0978-z CrossRefPubMed Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71. doi:10.​1007/​s00259-002-0978-z CrossRefPubMed
16.
Zurück zum Zitat Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127–135. doi:10.1002/hed.10037 CrossRefPubMed Brun E, Kjellen E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, Strand SE (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127–135. doi:10.​1002/​hed.​10037 CrossRefPubMed
17.
Zurück zum Zitat Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, Slosman DO (2002) Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20:1398–1404CrossRefPubMed Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, Slosman DO (2002) Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20:1398–1404CrossRefPubMed
18.
Zurück zum Zitat Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, Ouchi Y (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol 192:W156–W160. doi:10.2214/AJR.08.1429 CrossRefPubMed Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, Ouchi Y (2009) Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol 192:W156–W160. doi:10.​2214/​AJR.​08.​1429 CrossRefPubMed
20.
Zurück zum Zitat Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, Murthy V, Sengar M, Dinshaw KA (2009) Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy. Acta Oncol 48:1026–1033. doi:10.1080/02841860902845839 CrossRefPubMed Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, Murthy V, Sengar M, Dinshaw KA (2009) Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy. Acta Oncol 48:1026–1033. doi:10.​1080/​0284186090284583​9 CrossRefPubMed
21.
Zurück zum Zitat Ioannidis JP, Lau J (2003) 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 44:717–724PubMed Ioannidis JP, Lau J (2003) 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 44:717–724PubMed
22.
Zurück zum Zitat Ensley J, Crissman J, Kish J, Jacobs J, Weaver A, Kinzie J, Cummings G, Al-Sarraf M (1986) The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy. Cancer 57:711–717CrossRefPubMed Ensley J, Crissman J, Kish J, Jacobs J, Weaver A, Kinzie J, Cummings G, Al-Sarraf M (1986) The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapy. Cancer 57:711–717CrossRefPubMed
Metadaten
Titel
Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
verfasst von
Stephan K. Haerle
G. F. Huber
T. F. Hany
N. Ahmad
D. T. Schmid
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 10/2010
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1348-2

Weitere Artikel der Ausgabe 10/2010

European Archives of Oto-Rhino-Laryngology 10/2010 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.